{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:28Z","timestamp":1761630688591,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.annder.2014.04.123","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T05:43:25Z","timestamp":1401687805000},"page":"523-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dermatoneuro syndrome au cours d\u2019un scl\u00e9romyx\u0153d\u00e8me\u00a0: efficacit\u00e9 des plasmaph\u00e9r\u00e8ses et des immunoglobulines intraveineuses"],"prefix":"10.1016","volume":"141","author":[{"given":"S.","family":"Charles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Valette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Levillain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.04.123_bib0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","article-title":"Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG)","volume":"87","author":"Blum","year":"2008","journal-title":"Medecine"},{"key":"10.1016\/j.annder.2014.04.123_bib0010","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0190-9622(00)90274-3","article-title":"Scleromyxedema with dermato-neuro syndrome","volume":"42","author":"Gonzalez","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2133.2005.06710.x","article-title":"Dementia associated with scleromyxedema reversed by high-dose intravenous immunoglobulin","volume":"153","author":"Shergill","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0020","first-page":"78","article-title":"Scleromyxedema diagnosis following unexplained encephalopathy","volume":"18","author":"Rodriguez","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","article-title":"Fatal scleromyxedema: report of a case and review of the literature","volume":"38","author":"Godby","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0030","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.46.6.1778","article-title":"Fever, convulsions and coma in scleromyxedema: a \u201cdermato-neuro syndrome\u201d","volume":"46","author":"River","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2014.04.123_bib0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0190-9622(93)70021-K","article-title":"The association of potentially lethal neurological syndromes with scleromyxedema (papular mucinoses)","volume":"28","author":"Webster","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1749-6632.1998.tb09682.x","article-title":"The role of glycosphinglipids in neurological disorders","volume":"845","author":"Yu","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.annder.2014.04.123_bib0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.53.5.1138","article-title":"Encephalopathy in scleromyxedema","volume":"53","author":"Johkura","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.annder.2014.04.123_bib0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1067\/mjd.2000.104001","article-title":"Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIvIg)","volume":"43","author":"Lister","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0055","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","article-title":"Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin","volume":"60","author":"Rey","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ad.2011.04.015","article-title":"Escleromixedema y syndrome dermato-neuro: Buena respuesta al tratamiento con glucocorticoids e inmunoglobulinas endevenosas","volume":"103","author":"Bielsa","year":"2012","journal-title":"Actas Dermosifilogr"},{"key":"10.1016\/j.annder.2014.04.123_bib0065","first-page":"837","article-title":"Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts","volume":"16","author":"Ferrarini","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0560.2012.01882.x","article-title":"Scleromyxodema and the dermato-neuro syndrome: case report and review of the literature","volume":"39","author":"Fleming","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2014.04.123_bib0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-4632.2010.04691.x","article-title":"Scleromyxedema with monoclonal gammapathy and neurological involvement: recovery from coma after plasmapheresis?","volume":"51","author":"Do Prado","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0190-9622(88)70199-1","article-title":"Scleromyxedema: therapeutic response to isotretinoin in three patients","volume":"19","author":"Milam","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0085","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1365-2133.2001.04261.x","article-title":"Coma associated with scleromyxedema and interferon alfa therapy. Full recovery after steroids and cyclophosphamide combined with plasmapheresis","volume":"144","author":"Rongioletti","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.04.123_bib0090","first-page":"791","article-title":"Papular mucinoses, recurrent comas, and benign dysglobulinemia","volume":"143","author":"Verier","year":"1987","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.annder.2014.04.123_bib0095","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1365-2133.2007.08169.x","article-title":"Scleromyxedema: successful therapy with intravenous immunoglobulins","volume":"157","author":"Gholam","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814002786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814002786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:02:00Z","timestamp":1758970920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814002786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":19,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0151963814002786"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.04.123","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatoneuro syndrome au cours d\u2019un scl\u00e9romyx\u0153d\u00e8me\u00a0: efficacit\u00e9 des plasmaph\u00e9r\u00e8ses et des immunoglobulines intraveineuses","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.04.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}